相关实验视频

Updated: Sep 13, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

在慢性阻塞性肺病中生物治疗的成像终点

Muhammad F A Chaudhary¹, Surya P Bhatt²

¹Division of Pulmonary, Allergy, and Critical Care Medicine, UAB Heersink School of Medicine, Birmingham, AL, 35233.

The British journal of radiology

|July 31, 2025

概括

慢性阻塞性肺病 (COPD) 的恶化可以通过针对2型炎症的生物药物来减少. 像呼吸道壁厚度这样的成像生物标志物在临床试验中显示出追踪疾病修饰的前景.

科学领域:

肺部病理学肺部病理学
免疫学免疫学免疫学
放射学放射学是一门学科.

背景情况:

慢性阻塞性肺病 (COPD) 显著影响呼吸系统健康,以恶化和逐渐下降为标志.
特定的COPD内型包括2型炎症,与恶化和治疗反应增加有关.

研究的目的:

探索成像生物标志物的实用性,以评估生物治疗COPD患者的疾病修饰.
评估成像测量是否可以作为COPD治疗有效临床试验终点.

主要方法:

来自临床试验的证据的审查,主要是喘,重点是针对2型炎症的生物药物.
分析成像参数,如气道壁厚度,粘液堵塞和通风缺陷百分比等.

主要成果:

针对2型炎症的生物药物显示出降低COPD恶化和改善肺功能的潜力.
包括气道壁厚度和粘液堵塞在内的成像测量似乎可以通过生物疗法进行修改.

结论:

成像终点为评估COPD临床试验中的疾病修饰和结构重塑提供了有希望的方法.
这些终点可能会显著减少对COPD生物疗法进行研究的试验所需的样本大小.

关键词:

生物制剂生物制剂生物制剂慢性阻塞性肺病慢性阻塞性肺病计算机断层扫描 (CT) 是一种计算机断层扫描.磁共振成像技术磁共振成像技术治疗反应对治疗的反应.

更多相关视频

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on: April 13, 2018

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function

Published on: April 12, 2024

相关概念视频

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation